top of page
Aphios Pharma
Login to favorite a company
Aphios Pharma LLC, a wholly-owned subsidiary of Aphios Corporation, is dedicated to the discovery, delivery, development and commercialization of drugs to treat Central Nervous System (CNS) and other disorders with a focus on Opioid Addiction.
Most Recent Valuation:
$68,959,967.00
Legal Name:
Founded:
State of HQ:
Aphios Pharma LLC
7/6/2018
MA
Company Description
Employees:
[]
Funding Summary
Number of funding rounds
2
Total amount raised
Round name | End date | Raised | Status | Type | Investment minimum | Valuation | Valuation Cap | Price per share |
|---|---|---|---|---|---|---|---|---|
Aphios Pharma Common Stock 3 | $112,495.00 | open | Common Stock | $100 | $68,959,967 | 3.44 | ||
Aphios Pharma Stock 1 | closed | Common Stock | 1 |
See round history
Round history
Round name | Perk description | Perk level (dollars) | Perk level (days) |
|---|
Loading...
Early Bird Perk history
Company notes
Type | Round name | Date Added | Date Updated | Notes |
|---|
Loading...
Financials (up to prior 4 years)
Revenue
COGS
Gross margin | (%)
Taxes
SG&A, other
Net income
Cash/Equivalents
Accounts Receiv
Other Assets
Assets
Short term debt
Long term debt
Equity/other liabilities
Gross margin, Other Assets, and Equity/other liabilities are derived from the financial statements of the company reported to the SEC. Assets = Liabilities + Equity, and no equity accounts nor accounts payable are reported to the SEC, hence the possibility for that amount to be either equity or a liability.
bottom of page